csg-admin-2019

February 2, 2022

Genetic Engineering & Biotechnology News – Bitter Taste Receptors Represent a Therapeutic Sweet Spot

Stimulating bitter taste receptors, the body’s early warning system for toxic substances, can fight obesity and inflammation. By Gail Dutton – February 02, 2022 Bitter […]
February 2, 2022

Aardvark Therapeutics, Inc., Announces the Initiation of Enrollment for Three Phase 2 Clinical Trials Of Oral ARD-101

Two studies evaluate ARD-101 in Obesity: one in General Obesity and the other in Refractory Weight Gain Post-Bariatric Surgery. The 3rd clinical trial is in […]
January 20, 2022

Oxeia Biopharmaceuticals Announces New Board and Management Team Members and Relocates Corporate Headquarters To Boston

Boston, MA, January 20, 2022 – Oxeia Biopharmaceuticals, a clinical stage biotech company conducting Phase 2 clinical trials of OXE103 for treating concussion, today announced […]
November 3, 2021

Swiss Gondola Medical Technologies Announces Collaboration with New York’s Mount Sinai Health System to Study Innovative Treatment for Neurological Disorders Such as Parkinson’s Disease

Automated Peripheral Mechanical Stimulation improves patient mobility Non-invasive mechanical device stimulates nerves in patients’ feet Custom-fitted “boots” ensure contact points alignment Device is internationally patented […]